Profil
Mr. Steven P.
van Nurden is President & Chief Executive Officer at Fitzsimons Redevelopment Authority (Colorado).
He is on the Board of Directors at Anexon, Inc. and Colorado BioScience Association.
Mr. van Nurden also served on the board at Mayo Clinic Ventures.
Postes actifs de Steven P. van Nurden
| Sociétés | Poste | Début |
|---|---|---|
Colorado BioScience Association
Colorado BioScience Association Miscellaneous Commercial ServicesCommercial Services Operates as a association for life sciences | Directeur/Membre du Conseil | - |
Fitzsimons Redevelopment Authority (Colorado) | Directeur Général | - |
Anciens postes connus de Steven P. van Nurden
| Sociétés | Poste | Fin |
|---|---|---|
Anexon, Inc.
Anexon, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cardiovascular diseases | Directeur/Membre du Conseil | - |
Mayo Medical Ventures
Mayo Medical Ventures Investment ManagersFinance Mayo Medical Ventures invests in companies located in the United States. The firm focuses on companies operating in medical technology, medical devices, biopharmaceuticals, diagnostic sectors. It provides financing for early stage capital requirements. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Mayo Medical Ventures
Mayo Medical Ventures Investment ManagersFinance Mayo Medical Ventures invests in companies located in the United States. The firm focuses on companies operating in medical technology, medical devices, biopharmaceuticals, diagnostic sectors. It provides financing for early stage capital requirements. | Finance |
Colorado BioScience Association
Colorado BioScience Association Miscellaneous Commercial ServicesCommercial Services Operates as a association for life sciences | Commercial Services |
Anexon, Inc.
Anexon, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cardiovascular diseases | Health Technology |
Fitzsimons Redevelopment Authority (Colorado) | Government |
















